HSCA Announces 2019 Board of Directors and Names GNYHA Ventures President Lee Perlman Board Chair
Washington, DC (January, 2019) – The Healthcare Supply Chain Association (HSCA) today announced that GNYHA Ventures, Inc....
Learn MoreComments of the Healthcare Supply Chain Association to FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Food...
Learn MoreHSCA Statement on Senate HELP Committee Hearing on Reducing Costs through Innovation
Washington, DC (November 28, 2018) – Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph., today...
Learn MoreComments of the Healthcare Supply Chain Association (HSCA) to FDA on Facilitating Competition and Innovation in the Biological Products Marketplace
On behalf of the Healthcare Supply Chain Association (HSCA), thank you for the opportunity to provide comments on the U.S. Food...
Learn MoreHSCA Comments on DEA Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments on the U.S. Drug...
Learn MoreHSCA Releases Second Annual Report on Value GPOs Deliver to the Healthcare Supply Chain
Washington, DC (August 21, 2018) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading...
Learn MoreComments of the Healthcare Supply Chain Association on the Department of Health and Human Services Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the Department...
Learn MoreHSCA Applauds Senate Judiciary Committee for Advancing the CREATES Act
Washington, DC (June 14, 2018) – Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph., today released...
Learn MoreHSCA Joins Leading Healthcare Organizations in Supporting the CREATES Act (S.974)
We, the undersigned, commend you for your leadership and commitment to reducing out-of-control prescription drug prices and...
Learn More